trisequens has been researched along with betaxolol in 1 studies
| Studies (trisequens) | Trials (trisequens) | Recent Studies (post-2010) (trisequens) | Studies (betaxolol) | Trials (betaxolol) | Recent Studies (post-2010) (betaxolol) |
|---|---|---|---|---|---|
| 56 | 35 | 1 | 717 | 227 | 82 |
| Protein | Taxonomy | trisequens (IC50) | betaxolol (IC50) |
|---|---|---|---|
| Beta-1 adrenergic receptor | Homo sapiens (human) | 0.0371 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Britov, AN; Bystrova, MM; Eliseeva, NA; Gorbunov, VM; Lebedev, AV; Slasten, OP; Smetnik, VP | 1 |
1 trial(s) available for trisequens and betaxolol
| Article | Year |
|---|---|
[Hormone replacement therapy in women with arterial hypertension in peri- and postmenopause: hemodynamic effects].
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Betaxolol; Climacteric; Drug Combinations; Drug Therapy, Combination; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Hemodynamics; Humans; Hypertension; Middle Aged; Norethindrone; Postmenopause | 2001 |